Compare Summit Therapeutics Inc (SMMT) vs Trade Desk Inc (TTD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Trade Desk Inc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Trade Desk Inc trades at $18.25 (market cap $8.76B). The key difference: Summit Therapeutics Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| SMMT | TTD | |
|---|---|---|
Market Cap | $10.48B | $8.76B |
Sector | Health | Technology |
52-Week High | $29.32 | $89.76 |
52-Week Low | $13.05 | $17.33 |
Enterprise Value | $9.90B | $7.78B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →
